ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
60.74
-1.04 (-1.68%)
Jun 18, 2024, 4:00 PM EDT - Market closed

ANI Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 1997
Revenue
486.82316.39216.14208.48206.55
Upgrade
Revenue Growth (YoY)
53.87%46.38%3.67%0.93%2.47%
Upgrade
Cost of Revenue
181.51138.79100.6187.1663.15
Upgrade
Gross Profit
305.3177.6115.53121.32143.39
Upgrade
Selling, General & Admin
161.7124.0484.2964.9955.84
Upgrade
Research & Development
34.2922.3211.371619.81
Upgrade
Other Operating Expenses
61.0862.0963.556.8451.62
Upgrade
Operating Expenses
257.07208.46159.16137.83127.27
Upgrade
Operating Income
48.24-30.86-43.64-16.5116.12
Upgrade
Interest Expense / Income
26.9428.0511.929.4512.97
Upgrade
Other Expense / Income
1.433.760.5--
Upgrade
Pretax Income
19.87-62.67-56.06-25.963.16
Upgrade
Income Tax
1.09-14.77-13.46-3.41-2.94
Upgrade
Net Income
18.78-47.9-42.6-22.556.09
Upgrade
Preferred Dividends
1.631.630.1900
Upgrade
Net Income Common
17.15-49.52-42.79-22.556.09
Upgrade
Net Income Growth
-----60.67%
Upgrade
Shares Outstanding (Basic)
1816131212
Upgrade
Shares Outstanding (Diluted)
1816131212
Upgrade
Shares Change
11.89%29.09%5.28%-0.63%2.28%
Upgrade
EPS (Basic)
0.86-3.05-3.40-1.880.51
Upgrade
EPS (Diluted)
0.85-3.05-3.40-1.880.50
Upgrade
EPS Growth
-----61.54%
Upgrade
Free Cash Flow
110.09-39.333.419.1339
Upgrade
Free Cash Flow Per Share
6.05-2.420.270.763.24
Upgrade
Gross Margin
62.71%56.13%53.45%58.19%69.42%
Upgrade
Operating Margin
9.91%-9.75%-20.19%-7.92%7.81%
Upgrade
Profit Margin
3.52%-15.65%-19.80%-10.82%2.95%
Upgrade
Free Cash Flow Margin
22.61%-12.43%1.58%4.38%18.88%
Upgrade
Effective Tax Rate
5.50%----93.03%
Upgrade
EBITDA
107.8725.043.1228.1360.74
Upgrade
EBITDA Margin
22.16%7.91%1.44%13.49%29.40%
Upgrade
Depreciation & Amortization
61.0659.6547.2544.6444.61
Upgrade
EBIT
46.81-34.61-44.14-16.5116.12
Upgrade
EBIT Margin
9.62%-10.94%-20.42%-7.92%7.81%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).